Telomeres Parameters in Cirrhosis
NCT02131831 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2014-09-16
Summary
There are several factors that influence telomere length in patients with cirrhosis, such as metabolic derangements and infectious etiologies, The aim of the study is to compare telomere length and other parameters related to genetic instability in telomere/ telomerase system, in peripheral blood lymphocytes in cirrhosis from different etiologies.
Conditions
- Cirrhosis
Sponsors & Collaborators
-
Meir Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-06-30
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Pharmacokinetics and Safety of ALKS 5461 in Healthy Subjects and Subjects With Hepatic Impairment and Normal Hepatic Function
NCT02452801 ·Status: COMPLETED ·Phase: PHASE1
-
Stem Cell Transplantation in Patients With Primary Biliary Cirrhosis
NCT00393185 ·Status: WITHDRAWN ·Phase: PHASE1
-
TAK-242 in Patients With Acute Alcoholic Hepatitis
NCT04620148 ·Status: UNKNOWN ·Phase: PHASE2
-
Improvement of Liver Function in Liver Cirrhosis Patients After Autologous Mesenchymal Stem Cell Injection:a Phase I-II Clinical Trial
NCT00420134 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Pharmacokinetics of ACT-541468 in Subjects With Mild, Moderate, and Severe Hepatic Impairment
NCT03713242 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 1b/2, Open Label, Repeat Dose, Dose Escalation Study of ND-L02-s0201 Injection in Subjects With Moderate to Extensive Fibrosis (METAVIR F3-4)
NCT02227459 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Plasmapheresis in Patients of Drug-Induced Liver Injury (DILI) With Underlying Chronic Liver Disease
NCT06797011 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Phase II Safety Study of 2 Dose Regimens of HepaStem in Patients With ACLF
NCT02946554 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis
NCT00004784 ·Status: COMPLETED ·Phase: PHASE3
-
Multiple Dose Study for a New Medication to Potentially Treat Liver Diseases
NCT06891365 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of IDN-6556 in Subjects With Liver Cirrhosis
NCT02230670 ·Status: COMPLETED ·Phase: PHASE2
-
Intra-hepatic Artery Bone Marrow Derived Stem Cells Infusion for the Treatment of Advanced Liver Cirrhosis
NCT01412593 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver Fibrosis
NCT02400216 ·Status: COMPLETED
-
Long-term Follow-up Study of Livercellgram in Alcoholic LC Patients Who Completed Livercellgram Phase 2 Study
NCT02806011 ·Status: COMPLETED
-
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
NCT02968810 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A-TANGO Phase 2 Study
NCT06890039 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Clinical Trial of Umbilical Cord Mesenchymal Stem Cell Transfusion in Decompensated Liver Cirrhosis
NCT03529136 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease
NCT02927314 ·Status: COMPLETED ·Phase: PHASE2
-
The Effectiveness and Safety for Mesenchymal Stem Cell for Alcoholic Liver Cirrhosis
NCT01741090 ·Status: UNKNOWN ·Phase: PHASE2
-
A Clinical Trial Evaluating the Safety, Tolerability, and Preliminary Efficacy of HCL001 Cell Injection (Homologous Allogeneic Hepatocytes) in Patients With Decompensated Cirrhosis
NCT06306781 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhotic Primary Sclerosing Cholangitis (PSC)
NCT07229911 ·Status: RECRUITING ·Phase: PHASE1
-
Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function
NCT02808312 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study to Evaluate the Safety and Efficacy of Mesenchymal Stem Cells in Liver Cirrhosis
NCT01877759 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Autologous Mesenchymal Stem Cell Transplantation in Liver Cirrhosis
NCT01499459 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Laparoscopic Splenectomy on Liver Reserve Function for Cirrhosis Patients
NCT05325424 ·Status: RECRUITING ·Phase: NA